INiBICA

In response to the callfor “EXPRESSIONS OF INTEREST FOR RESEARCH- Projects S ON SARS-COV-2 AND COVID-19 FROM THE ISCIII,” the INIBICA CO-10 Group,“Molecular Immunology and Genic and Cellular Immunotherapy,has secured 100,000 euros to fund a research project titled“Nanosensor-Based Diagnosis and Rapid Identification in Solution of Disruptors of the Interaction Between the SARS-CoV-2 virus with its cellular receptor (NANOCOMPETE),” whose Principal Investigator (from the Immunology Department at the UCA), Mr. Francisco García Cózar , will focus on developing new innovative therapies. In collaboration with Mr. Daniel Ortega Ponce (who recently joined the Department of Condensed Matter Physics at the UCA), they will develop a new technique for rapid virological diagnosis of SARS-CoV-2.



💰🔬 The Spanish National Research Council ( ISCIII ) is providing 100,000 euros in funding for a COVID-19 research project led by INiBICA 🔬💰 - INiBICA

Tres moléculas de la proteína viral “spike”
uniéndose al receptor celular ACE2 (en verde)
permitiendo la entrada del virus en la célula
(Daniel Wrapp et al. Science 2020)

Privacy Summary

This website uses cookies so that we can provide you with the best possible user experience. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website or helping our Team understand which sections of the website you find most interesting and useful.